Page last updated: 2024-10-22

pimagedine and Experimental Pneumococcal Meningitis

pimagedine has been researched along with Experimental Pneumococcal Meningitis in 2 studies

pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoffmann, O1
Zweigner, J1
Smith, SH1
Freyer, D2
Mahrhofer, C1
Dagand, E1
Tuomanen, EI1
Weber, JR2
Angstwurm, K1
Dirnagl, U1
Hanisch, UK1
Schumann, RR1
Einhäupl, KM1

Other Studies

2 other studies available for pimagedine and Experimental Pneumococcal Meningitis

ArticleYear
Interplay of pneumococcal hydrogen peroxide and host-derived nitric oxide.
    Infection and immunity, 2006, Volume: 74, Issue:9

    Topics: Animals; Carbamoyl-Phosphate Synthase (Ammonia); Cells, Cultured; Disease Models, Animal; Gene Delet

2006
Tumour necrosis factor alpha induces only minor inflammatory changes in the central nervous system, but augments experimental meningitis.
    Neuroscience, 1998, Volume: 86, Issue:2

    Topics: Animals; Body Water; Brain; Cell Wall; Cerebrovascular Circulation; Dose-Response Relationship, Drug

1998